Market Overview

Herbalife Shares Edge Higher; Wedbush Boosts Target to $90, Analyst Shows No Concern on Nu Skin Product

Share:
Related HLF
Benzinga's $3 Million Investment Round Will Continue To Make Information Easier For You To Consume
12 Biggest Mid-Day Gainers For Wednesday
Calling Icahn's Bluff On Herbalife (Seeking Alpha)
Related NUS
Growth In China Believed To Be The Driver Behind Nu Skin Enterprise's New Guidance
Citi Meets With Nu Skin Management: 'We Liked What We Heard On The Road'

Shares of Herbalife (NYSE: HLF) are trading up about a percent Friday morning as traders are cheering a boosted price target from Wedbush's Rommel Dionisio.

Dionisio now expects Herbalife shares to rise to $90 over the next year, up from $80 previously.

The analyst believes Herbalife will be buying back additional shares more aggressively on the heels of the recent re-audit conclusion. Dionisio noted the firm's distributor checks are indicating "not even a slight" slowdown in sales growth following the unveiling of a new Nu Skin (NYSE: NUS) product.

Wedbush maintains an Outperform rating on shares of Herbalife.

With Herbalife shares last trading around $79.50, Dionisio's new price target implies potential upside of about 13 percent.

Latest Ratings for HLF

DateFirmActionFromTo
Apr 2016BarclaysTerminatesOverweightOverweight
Aug 2015Pivotal ResearchMaintainsBuy
May 2015Canaccord GenuityMaintainsBuy

View More Analyst Ratings for HLF
View the Latest Analyst Ratings

Posted-In: Analyst Color News Price Target Analyst Ratings

 

Related Articles (HLF + NUS)

View Comments and Join the Discussion!